These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11472371)

  • 41. Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse.
    Bader P; Stoll K; Huber S; Geiselhart A; Handgretinger R; Niemeyer C; Einsele H; Schlegel PG; Niethammer D; Beck J; Klingebiel T
    Br J Haematol; 2000 Mar; 108(4):761-8. PubMed ID: 10792281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia.
    Ramírez M; Díaz MA; García-Sánchez F; Velasco M; Casado F; Villa M; Vicario JL; Madero L
    Bone Marrow Transplant; 1996 Dec; 18(6):1161-5. PubMed ID: 8971389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors.
    de la Fuente J; Reiss S; McCloy M; Vulliamy T; Roberts IA; Rahemtulla A; Dokal I
    Bone Marrow Transplant; 2003 Oct; 32(7):653-6. PubMed ID: 13130311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study.
    Straathof KC; Rao K; Eyrich M; Hale G; Bird P; Berrie E; Brown L; Adams S; Schlegel PG; Goulden N; Gaspar HB; Gennery AR; Landais P; Davies EG; Brenner MK; Veys PA; Amrolia PJ
    Lancet; 2009 Sep; 374(9693):912-20. PubMed ID: 19729196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia.
    McCann S; Passweg J; Bacigalupo A; Locasciulli A; Locatelli F; Ryan J; Schrezenmeier H; Lawler M
    Bone Marrow Transplant; 2007 Jan; 39(2):109-14. PubMed ID: 17173053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treosulfan-containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non-malignant disease and significant co-morbidities.
    Greystoke B; Bonanomi S; Carr TF; Gharib M; Khalid T; Coussons M; Jagani M; Naik P; Rao K; Goulden N; Amrolia P; Wynn RF; Veys PA
    Br J Haematol; 2008 Jun; 142(2):257-62. PubMed ID: 18492115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
    Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning.
    Panse JP; Heimfeld S; Guthrie KA; Maris MB; Maloney DG; Baril BB; Little MT; Chauncey TR; Storer BE; Storb R; Sandmaier BM
    Br J Haematol; 2005 Mar; 128(5):659-67. PubMed ID: 15725088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
    Baron F; Maris MB; Storer BE; Sandmaier BM; Panse JP; Chauncey TR; Sorror M; Little MT; Maloney DG; Storb R; Heimfeld S
    Leukemia; 2005 May; 19(5):822-8. PubMed ID: 15772701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transplant Outcomes in Beta-Thalassemia Major Patients Receiving Combined Granulocyte Colony-Stimulating Factor-Primed Bone Marrow and Cord Blood Graft Compared to Granulocyte Colony-Stimulating Factor-Primed Bone Marrow Alone.
    Wen J; Haque Q; Pei F; Chen L; Ruan Y; Liu X; He Y; Feng X; Li C; Wu X
    Acta Haematol; 2018; 140(1):20-29. PubMed ID: 30071526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
    La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
    Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation.
    Griffith LM; McCoy JP; Bolan CD; Stroncek DF; Pickett AC; Linton GF; Lundqvist A; Srinivasan R; Leitman SF; Childs RW
    Br J Haematol; 2005 Mar; 128(5):668-75. PubMed ID: 15725089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.
    Yoshimi A; Niemeyer CM; Bohmer V; Duffner U; Strahm B; Kreyenberg H; Dilloo D; Zintl F; Claviez A; Wössmann W; Kremens B; Holter W; Niethammer D; Beck JF; Kontny U; Nöllke P; Klingebiel T; Bader P
    Br J Haematol; 2005 May; 129(4):542-9. PubMed ID: 15877738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection.
    Dubovsky J; Daxberger H; Fritsch G; Printz D; Peters C; Matthes S; Gadner H; Lion T; Muller-Bérat N
    Leukemia; 1999 Dec; 13(12):2059, 2060-9. PubMed ID: 10602430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantation.
    Wäsch R; Bertz H; Kunzmann R; Finke J
    Br J Haematol; 2000 Jun; 109(4):743-50. PubMed ID: 10929024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.
    Shenoy S; Thompson AA
    Ann N Y Acad Sci; 2016 Mar; 1368(1):122-6. PubMed ID: 26999376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful HSCT using nonradiotherapy-based conditioning regimens and alternative donors in patients with Fanconi anaemia--experience in a single UK centre.
    Motwani J; Lawson SE; Darbyshire PJ
    Bone Marrow Transplant; 2005 Sep; 36(5):405-10. PubMed ID: 15995715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Relationship between cellular immune function during conditioning and graft rejection in patients with beta-thalassemia major].
    Hao WG; Huang SL; Sun X; Liu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1375-7. PubMed ID: 19620057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.